vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $38.3M, roughly 1.3× ImmunityBio, Inc.). First Foundation Inc. runs the higher net margin — -97.9% vs -161.8%, a 63.9% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 407.0%). First Foundation Inc. produced more free cash flow last quarter ($-35.2M vs $-71.3M).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
FFWM vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $38.3M |
| Net Profit | $-8.0M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | -97.5% | -169.0% |
| Net Margin | -97.9% | -161.8% |
| Revenue YoY | 421.7% | 407.0% |
| Net Profit YoY | 43.0% | -4.7% |
| EPS (diluted) | $-0.09 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $38.3M | ||
| Q3 25 | $63.6M | $32.1M | ||
| Q2 25 | $51.4M | $26.4M | ||
| Q1 25 | $71.4M | $16.5M | ||
| Q4 24 | $9.3M | $7.6M | ||
| Q3 24 | $9.2M | $6.1M | ||
| Q2 24 | $57.5M | — | ||
| Q1 24 | $51.1M | — |
| Q4 25 | $-8.0M | $-61.9M | ||
| Q3 25 | $-146.3M | $-67.3M | ||
| Q2 25 | $-7.7M | $-92.6M | ||
| Q1 25 | $6.9M | $-129.6M | ||
| Q4 24 | $-14.1M | $-59.2M | ||
| Q3 24 | $-82.2M | $-85.7M | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $793.0K | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -97.5% | -169.0% | ||
| Q3 25 | -92.7% | -173.5% | ||
| Q2 25 | -21.1% | -269.8% | ||
| Q1 25 | 8.8% | -390.1% | ||
| Q4 24 | -247.7% | -919.0% | ||
| Q3 24 | -1276.7% | -1314.3% | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | -0.2% | — |
| Q4 25 | -97.9% | -161.8% | ||
| Q3 25 | -230.1% | -209.8% | ||
| Q2 25 | -15.0% | -350.3% | ||
| Q1 25 | 9.7% | -784.9% | ||
| Q4 24 | -152.2% | -783.4% | ||
| Q3 24 | -896.9% | -1404.0% | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | $-0.09 | $-0.06 | ||
| Q3 25 | $-1.78 | $-0.07 | ||
| Q2 25 | $-0.09 | $-0.10 | ||
| Q1 25 | $0.08 | $-0.15 | ||
| Q4 24 | $-0.24 | $-0.08 | ||
| Q3 24 | $-1.23 | $-0.14 | ||
| Q2 24 | $0.05 | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $912.6M | $-500.5M |
| Total Assets | $11.9B | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | $242.8M | ||
| Q3 25 | $1.7B | $257.8M | ||
| Q2 25 | $1.1B | $153.7M | ||
| Q1 25 | $1.0B | $61.6M | ||
| Q4 24 | $1.0B | $149.8M | ||
| Q3 24 | $1.1B | $130.4M | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $912.6M | $-500.5M | ||
| Q3 25 | $917.9M | $-524.3M | ||
| Q2 25 | $1.1B | $-570.7M | ||
| Q1 25 | $1.1B | $-591.4M | ||
| Q4 24 | $1.1B | $-489.1M | ||
| Q3 24 | $1.1B | $-745.1M | ||
| Q2 24 | $933.2M | — | ||
| Q1 24 | $928.7M | — |
| Q4 25 | $11.9B | $501.9M | ||
| Q3 25 | $11.9B | $519.0M | ||
| Q2 25 | $11.6B | $402.1M | ||
| Q1 25 | $12.6B | $303.8M | ||
| Q4 24 | $12.6B | $382.9M | ||
| Q3 24 | $13.4B | $364.6M | ||
| Q2 24 | $13.7B | — | ||
| Q1 24 | $13.6B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $-70.4M |
| Free Cash FlowOCF − Capex | $-35.2M | $-71.3M |
| FCF MarginFCF / Revenue | -72.8% | -186.2% |
| Capex IntensityCapex / Revenue | 6.9% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | $-70.4M | ||
| Q3 25 | $9.2M | $-68.9M | ||
| Q2 25 | $-16.3M | $-79.7M | ||
| Q1 25 | $-552.0K | $-85.9M | ||
| Q4 24 | $-8.7M | $-85.1M | ||
| Q3 24 | $14.2M | $-98.8M | ||
| Q2 24 | $-9.1M | — | ||
| Q1 24 | $7.2M | — |
| Q4 25 | $-35.2M | $-71.3M | ||
| Q3 25 | $8.6M | $-69.6M | ||
| Q2 25 | $-16.7M | $-80.8M | ||
| Q1 25 | $-2.5M | $-87.0M | ||
| Q4 24 | $-11.4M | $-87.3M | ||
| Q3 24 | $13.4M | $-101.6M | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $5.9M | — |
| Q4 25 | -72.8% | -186.2% | ||
| Q3 25 | 13.5% | -217.2% | ||
| Q2 25 | -32.4% | -305.9% | ||
| Q1 25 | -3.5% | -526.9% | ||
| Q4 24 | -123.5% | -1155.4% | ||
| Q3 24 | 146.2% | -1663.2% | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | 11.6% | — |
| Q4 25 | 6.9% | 2.4% | ||
| Q3 25 | 1.0% | 2.3% | ||
| Q2 25 | 0.8% | 4.1% | ||
| Q1 25 | 2.8% | 6.8% | ||
| Q4 24 | 29.4% | 28.0% | ||
| Q3 24 | 9.0% | 45.7% | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.96× | — | ||
| Q1 24 | 9.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
